SCHEMBL20614745

SCHEMBL20614745

CN(C)/C=C1/CCN(C)c2cnccc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ SMARCA4 P51532 1/20 0.36
▸ CYP3A4 P08684 2/20 0.33
▸ PBRM1 Q86U86 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ HTT P42858 3/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ LMNA P02545 2/20 0.32
▸ MITF O75030 1/20 0.32
▸ CYP46A1 Q9Y6A2 2/20 0.32
▸ NPC1 O15118 2/20 0.31
▸ BLM P54132 2/20 0.31
▸ TP53 P04637 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20614927 0.90 KDM4E (0.38) MEN1KMT2AKDM4ESMARCA4CYP3A4
SCHEMBL20614794 0.83 KDM4E (0.35) MEN1KMT2AKDM4ESMARCA4PBRM1
SCHEMBL19151284 0.81 MEN1 (0.51) MEN1KMT2AKDM4ESMARCA4MAPT
SCHEMBL7241088 0.76 KMT2A (0.49) MEN1KMT2AKDM4EMAPTSMN1; SMN2
SCHEMBL7241092 0.76 KMT2A (0.49) MEN1KMT2AKDM4EMAPTSMN1; SMN2
SCHEMBL20614928 0.75 KDM4E (0.35) MEN1KMT2AKDM4ESMARCA4CYP3A4
SCHEMBL20614685 0.74 SMARCA4 (0.38) MEN1KMT2AKDM4ESMARCA4PBRM1
SCHEMBL19150902 0.72 ALDH1A1 (0.36) MEN1KMT2AKDM4ESMARCA4PBRM1
SCHEMBL20614744 0.70 PLK1 (0.39) MEN1KMT2ACYP3A4MAPTCYP2D6
SCHEMBL20614746 0.68 CDC25B (0.35) MEN1KMT2AKDM4ECYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019006291-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-01-03 — — WO disclosed
Send feedback